CervoMed Inc. (CRVO) Insider Trading & SEC Filings
Last SEC filing
CervoMed Inc. (CRVO) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-15. Insiders disclosed 3 open-market purchases totaling $3.00M. 9 Form 8-K material event filings were reported by CRVO in the last 90 days. InsiderAlpha tracks every CRVO SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About CervoMed Inc. (CRVO)
CervoMed Inc. trades under the ticker CRVO. InsiderAlpha tracks 35 primary SEC Form 4 filings from 12 reporting insiders for CRVO since 2025, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001053691 |
90-Day SEC Filing Activity
| Insider purchases (90d) | 3 ($3.00M) |
|---|---|
| Form 4 filings (90d) | 9 |
| Form 8-K filings (90d) | 9 |
| Latest Form 4 filing | 2026-06-15 |
Recent CRVO Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Joshua S. Boger | Director | P - Open-market purchase | 955.4K | $3.14 | $3.00M | SEC | |
| Matthew Winton | Chief Commercial and Business | P - Open-market purchase | 1.5K | $7.95 | $12K | SEC | |
| William Robert Elder | CFO, GC & Secretary | P - Open-market purchase | 2.5K | $8.32 | $21K | SEC | |
| Matthew Winton | Chief Commercial and Business | P - Open-market purchase | 3.5K | $8.43 | $30K | SEC | |
| Sylvie Gregoire | Director | P - Open-market purchase | 10.8K | $8.46 | $91K | SEC | |
| Sylvie Gregoire | Director | P - Open-market purchase | 10.8K | $8.46 | $91K | SEC | |
| John J. Alam | CEO & President | P - Open-market purchase | 10.8K | $8.46 | $91K | SEC | |
| John J. Alam | CEO & President | P - Open-market purchase | 10.8K | $8.46 | $91K | SEC | |
| William Robert Elder | CFO, GC & Secretary | P - Open-market purchase | 1.0K | $8.45 | $8K | SEC | |
| Matthew Winton | Chief Commercial and Business | P - Open-market purchase | 10.0K | $7.57 | $76K | SEC | |
| John J. Alam | CEO & President | P - Open-market purchase | 1.7K | $7.55 | $13K | SEC | |
| John J. Alam | CEO & President | P - Open-market purchase | 1.7K | $7.57 | $13K | SEC | |
| Sylvie Gregoire | Director | P - Open-market purchase | 1.7K | $7.55 | $13K | SEC | |
| Sylvie Gregoire | Director | P - Open-market purchase | 1.7K | $7.57 | $13K | SEC | |
| Sylvie Gregoire | Director | P - Open-market purchase | 4.4K | $7.51 | $33K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for CervoMed Inc. (CRVO). Updated in real time as new filings are submitted to the SEC.
Most-Active CRVO Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Joshua S. Boger | 4 | $3.00M |
| Sylvie Gregoire | 1 | - |
| Jane H. Hollingsworth | 1 | - |
| Marwan Sabbagh | 1 | - |
| Frank Zavrl | 1 | - |
Recent CRVO Form 8-K Material Events
- - Item 7.01, 8.01, 9.01 [SEC]
- - Item 7.01, 8.01, 9.01 [SEC]
- - Item 7.01, 8.01, 9.01 [SEC]
- - Item 1.01, 3.02, 8.01, 9.01 [SEC]
- - Item 8.01, 9.01 [SEC]
Recent Insider Filings
- - Joshua S. Boger (Director)
- - Frank Zavrl (Director)
- - Marwan Sabbagh (Director)
- - David Quigley (Director)
- - Jeffrey V. Poulton (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CRVO insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
CRVO Insider Trading - FAQ
- What is the latest insider trade for CRVO?
- CervoMed Inc. (CRVO) had 9 insider filings in the last 90 days, with the most recent on 2026-06-15. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying CRVO stock?
- 3 insider purchases of CRVO were filed in the last 90 days, totaling $3.00M.
- How many insiders are selling CRVO stock?
- 0 insider sales of CRVO were filed in the last 90 days.
- Where can I see CRVO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks CRVO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $CTTH CTT PHARMACEUTICAL HOLDINGS, INC.
- $CV CapsoVision, Inc
- $CVKD Cadrenal Therapeutics, Inc.
- $CVM CEL SCI CORP
- $DGX QUEST DIAGNOSTICS INC
- $DMAC DiaMedica Therapeutics Inc.
- $DVA DAVITA INC.
- $DXCM DEXCOM INC
- $EDGM Edgemode, Inc.
- $ELV Elevance Health, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live CRVO dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.